Antigenics
Latest round
- Series D
Last raised
- Jan 1999
Total raised
- $28M
Investors
- 3
About Antigenics
Based in Lexington, US, Antigenics is a biotechnology company focused on technology and products to treat cancers, infectious diseases, and autoimmune disorders.
Who invested in Antigenics
3 investors across 1 round
See all investors in Antigenics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jan 11, 1999
Amount
$28M
Investors
Questions about Antigenics
Who invested in Antigenics?
Antigenics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antigenics raised?
Antigenics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Antigenics last raise money?
Antigenics's most recent round on record is a Series D, in Jan 1999.
What does Antigenics do?
Based in Lexington, US, Antigenics is a biotechnology company focused on technology and products to treat cancers, infectious diseases, and autoimmune disorders.
Where is Antigenics headquartered?
Antigenics is headquartered in Lexington, US.
Which VCs invest in companies like Antigenics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Antigenics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Antigenics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.